Learning Objectives
Upon completion of this activity, participants should be able to:
- Articulate the options for cytotoxic and targeted agents as first-line treatment of a patient with metastatic colorectal cancer and Gilbert’s syndrome
- Describe the surgical considerations for primary tumors for a patient with metastatic colorectal cancer and Gilbert’s syndrome
- Relate strategies for addressing treatment-induced neuropathy during administration of an oxaliplatin-based regimen for a patient with metastatic colorectal cancer and Gilbert’s syndrome
Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.